Three studies—one of mice and two of human genetics—describe the role of two proteins, adenylyl cyclase and melanocortin 4 receptor, in the development of obesity and diabetes.
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
A background in physiotherapy helps the Oxford-based researcher mix basic science with clinical work to better understand pain stemming from nerve compression.
Meet some of the people featured in the January 2018 issue of The Scientist.
For nearly 30 years, the UC San Francisco researcher has delved into unexplored corners of the nervous system.
Researchers map brain activity associated with a person’s anticipation of or direct confrontation with danger.
Immune-like cells in the central nervous system are now recognized as key participants in the creation and maintenance of persistent pain.
Since the mid-2000s, the voltage-gated sodium channel NaV1.7 has emerged as a promising target for a new class of analgesics.
The brain is activated differently when it’s contemplating, rather than directly facing, a threat.
The acute pain that results from injury or disease is very different from chronic pain.
The nationwide experiment will initially include around 100,000 volunteers.
After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
Researchers deliver small interfering RNAs loaded into nanoparticles into the ears of adult guinea pigs to regenerate hair cells damaged by noise.
The US Senate narrowly approved the politician, who does not have a science background.
© 1986-2018 The Scientist
